FORT ST. JOHN, B.C. – Eight athletes from the Fort St. John area will be representing the North Peace this week at the Special Olympics B.C. Summer Games in Kamloops.The Fort St. John branch of SOBC Kathy Turney says that this will be the biggest group of athletes heading to the Summer Games in B.C., comprised of eight athletes and two coaches. One of the group’s athletes no longer resides in the Energetic City, but still competes for the Northern B.C. Zone.Mykaela Stewart and Britni Renaud will be competing in the sport of Rhythmic Gymnastics. Sheryl Jakubowski will be the group’s lone athlete competing in athletics. Wyatt Turney and Nicholas Mitchell will be joined by two others from Quesnel and will form a team that is competing in both 5- and 10-pin bowling.- Advertisement -The pool will see a total of three swimmers from Fort St. John competing. Russell Wheat, Miranda Laboucane, and Tina Tompkins will be competing in Aquatics. Turney says that seven members of the team will be leaving Fort St. John tomorrow at 12:30 a.m. for their bus trip to Kamloops, ahead of the Summer Games’ opening ceremony on Thursday evening. The opening ceremonies will be streamed live on the Special Olympics B.C. Facebook page.
Jul 12 2018A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug.”This is both a remarkable scientific discovery and also something that has the potential to positively affect not only global health but also the economy of Canada,” said Fred West, professor in the Department of Chemistry who led the new discovery along with David Marchant in the Department of Medical Microbiology and Immunology. The compound is similar to the naturally occurring isatisine A, an antiviral compound originally found in traditional Chinese herbal medicine.Related StoriesResearchers succeed in conquering chronic infection with hepatitis B virusResearchers compare American, Pacific and Southeast Asian subtypes of Zika virusResearch sheds light on how hepatitis B virus establishes chronic infectionWorking in conjunction with Tom Hobman in the Faculty of Medicine & Dentistry, West and Marchant developed and then tested this chemical compound against powerful viruses, including RSV and Zika virus. The results were promising, showing that the chemical compound was active and effective against both viral infections.Hobman is a professor of cell biology and an expert in the Zika virus, a pathogen that can cause serious prenatal defects in pregnant women that has been on the public radar since a major outbreak in May 2015. Marchant is a professor of medical microbiology and an expert in RSV, which poses the biggest risk to infants, the elderly, and the immunocompromised. The virus can be responsible for more than 30 per cent of all hospitalized respiratory cases in any given year.The next step of drug development is already underway. “What we aim to do is further refine this compound, to keep the elements that make it medically active and build in the structural components that make it possible for patients to consume in drug form,” explained West. “We are approaching that point.”Marchant has started a company, Antibiddies Technologies Inc., that will license the intellectual property and begin commercialization.Source: https://www.ualberta.ca/science/science-news/2018/july/new-compounds-to-treat-rsv-zika-virus